Clinical Trial

Anesthesia Maintenance With Target-controlled Infusion of Propofol and Remifentanil at Fixed Ratio

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The impact of anesthesia depths on early postoperative neurocognitive complications after total intravenous anesthesia (TIVA) remains controversial. In some studies investigating TIVA, anesthesiologists mainly achieve the target depth of anesthesia by adjusting the dose of propofol, whereas the doses of opioids remains comparable between different anesthetic depth groups, possibly resulting inadequate analgesia. This study is aimed to investigate the impact of different anesthesia depths maintained by target-controlled infusion of propofol and remifentanil at a fixed ratio on the incidence of early postoperative neurocognitive complications in older patients undergoing noncardiac surgery.
Trial Details
NCT Number NCT07479719
Lead Sponsor Peking University First Hospital
Conditions Elderly, Surgery, Depth of Anesthesia, Total Intravenous Anesthesia, Delayed Neurocognitive Recovery
Enrollment 200 participants
Start Date 2026-04
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-18